Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
THMO | F | ThermoGenesis Holdings, Inc. | -18.65 | |
BCTX | F | BriaCell Therapeutics Corp. | -9.29 | |
APTO | F | Aptose Biosciences, Inc. | -3.36 | |
ALPN | F | Alpine Immune Sciences, Inc. | 0.00 | |
CERO | F | CERo Therapeutics Holdings, Inc. | 2.84 | |
TVGN | F | Tevogen Bio Holdings Inc. | 1.43 | |
TCBP | F | TC BioPharm (Holdings) plc | -1.20 | |
DBVT | F | DBV Technologies S.A. | -0.91 | |
SABS | F | SAB Biotherapeutics, Inc. | -8.75 | |
TLSI | F | TriSalus Life Sciences, Inc. | 0.94 |
Related Industries: Biotechnology Broadcasting - TV Diagnostics & Research Medical Care Medical Devices Other
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EWK | B | iShares MSCI Belgium Capped Investable Market Index Fund | 6.71 | |
BBH | A | Market Vectors Biotech ETF | 5.12 | |
IBRN | B | iShares Neuroscience and Healthcare ETF | 4.6 | |
MNTL | A | Tema Neuroscience and Mental Health ETF | 4.24 | |
FBT | B | First Trust Amex Biotech Index Fund | 3.7 |
Compare ETFs
- Immunotherapy
Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
Popular Now
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles